As of Dec 01
| +0.01 / +0.76%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.25, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +221.97% increase from the last price of 1.32.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.